Asia Pacific Embolotherapy Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Embolotherapy Market – by Product

1.3.2 Asia Pacific Embolotherapy Market – by Disease Indication

1.3.3 Asia Pacific Embolotherapy Market – by Procedure

1.3.4 Asia Pacific Embolotherapy Market – by End User

1.3.5 Asia Pacific Embolotherapy Market– By Country

2. Asia Pacific Embolotherapy Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Embolotherapy Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Boosting Patient Preference for Minimally Invasive Procedures

5.1.2 Surging Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2 Market Restraints

5.2.1 Accessibility of Other Alternative Therapies

5.3 Market Opportunity

5.3.1 Widening Applications of Embolotherapy

5.4 Market Trend

5.4.1 Growing Use of Liquid Embolic Agents

5.5 Impact analysis

6. Asia Pacific Embolotherapy Market Analysis

6.1 Asia Pacific Embolotherapy Market Revenue Forecast and Analysis

7. Asia Pacific Embolotherapy Market – by Product

7.1 Overview

7.2 Asia Pacific Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

7.3 Embolic Agents

7.3.1 Overview

7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3 Microspheres

7.3.3.1 Overview

7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4 Embolic Coils

7.3.4.1 Overview

7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5 Embolic Plug Systems

7.3.5.1 Overview

7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6 Detachable Balloons

7.3.6.1 Overview

7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7 Liquid Embolic Agents

7.3.7.1 Overview

7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8 Others

7.3.8.1 Overview

7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Support Devices

7.4.1 Overview

7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3 Microcatheters

7.4.3.1 Overview

7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4 Guidewires

7.4.4.1 Overview

7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Embolotherapy Market Analysis – by Disease Indication

8.1 Overview

8.2 Asia Pacific Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

8.3 Cancer

8.3.1 Overview

8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Liver Cancer

8.3.2.1.1 Overview

8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Kidney Cancer

8.3.2.2.1 Overview

8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Other Cancers

8.3.2.3.1 Overview

8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Peripheral Vascular Diseases

8.4.1 Overview

8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurological Diseases

8.5.1 Overview

8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Urological and Nephrological Disorders

8.6.1 Overview

8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Gastrointestinal Disorders

8.7.1 Overview

8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Embolotherapy Market Analysis – by Procedure

9.1 Overview

9.2 Asia Pacific Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

9.3 Transcatheter Arterial Embolization (TAE)

9.3.1 Overview

9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

9.4.1 Overview

9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Transarterial Chemoembolization (TACE)

9.5.1 Overview

9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Embolotherapy Market Analysis – By End User

10.1 Overview

10.2 Asia Pacific Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Ambulatory Surgical Centers

10.4.1 Overview

10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Other End Users

10.5.1 Overview

10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11. Asia Pacific Embolotherapy Market – Country Analysis

11.1 Overview

11.1.1 Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)

11.1.1.1 China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1 Overview

11.1.1.1.2 China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3 China Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3.1 China Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3.2 China Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4 China Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.4.1 China Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.5 China Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.6 China Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2 Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1 Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2 Japan Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.1 Japan Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.2.2 Japan Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3 Japan Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3.1 Japan Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.4 Japan Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.5 Japan Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1 Overview

11.1.1.3.2 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.3 India: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3.1 India: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3.2 India: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4 India: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.4.1 India: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.5 India: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.6 India: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.4 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1 Overview

11.1.1.4.2 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.3 South Korea: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.3.1 South Korea: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.3.2 South Korea: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.4 South Korea: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.4.1 South Korea: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.5 South Korea: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.6 South Korea: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.5 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.1 Overview

11.1.1.5.2 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.3 Australia: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.3.1 Australia: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.3.2 Australia: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.4 Australia: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.4.1 Australia: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.5 Australia: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.5.6 Australia: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

11.1.1.6 Rest of Asia Pacific: Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.1 Overview

11.1.1.6.2 Rest of Asia Pacific: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3 Rest of Asia Pacific: Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3.1 Rest of Asia Pacific: Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3.2 Rest of Asia Pacific: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.4 Rest of Asia Pacific: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.4.1 Rest of Asia Pacific: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.5 Rest of Asia Pacific: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.6 Rest of Asia Pacific: Embolotherapy Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12. Asia Pacific Embolotherapy Market –Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Boston Scientific Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Johnson & Johnson

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Medtronic

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Acandis GmbH

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Balt USA LLC

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Stryker Corporation

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Guerbet LLC

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Terumo Corporation

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. China Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. China Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 3. China Embolotherapy Market, by Support Device – Revenue and Forecast to 2028 (US$ Million)

Table 4. China Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 5. China Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)

Table 6. China Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 7. China Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 8. Japan Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 9. Japan Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)

Table 10. Japan Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 11. Japan Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 12. Japan Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 13. Japan Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 14. Japan Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)

Table 15. India: Embolotherapy Market, By Product – Revenue and Forecast To 2028 (US$ Million)

Table 16. India: Embolotherapy Market, By Embolic Agents – Revenue and Forecast To 2028 (US$ Million)

Table 17. India: Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)

Table 18. India: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19. India: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 20. India: Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)

Table 21. India: Embolotherapy Market, By End User– Revenue and Forecast To 2028 (US$ Million)

Table 22. South Korea: Embolotherapy Market, By Product – Revenue and Forecast To 2028 (US$ Million)

Table 23. South Korea: Embolotherapy Market, By Embolic Agents – Revenue and Forecast To 2028 (US$ Million)

Table 24. South Korea: Embolotherapy Market, By Support Devices – Revenue and Forecast To 2028 (US$ Million)

Table 25. South Korea: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 26. South Korea: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 27. South Korea: Embolotherapy Market, By Procedure – Revenue and Forecast To 2028 (US$ Million)

Table 28. South Korea: Embolotherapy Market, By End User– Revenue and Forecast To 2028 (US$ Million)

Table 29. Australia: Embolotherapy Market, By Product – Revenue and Forecast To 2028 (US$ Million)

Table 30. Australia: Embolotherapy Market, By Embolic Agents – Revenue and Forecast To 2028 (US$ Million)

Table 31. Australia: Embolotherapy Market, By Support Devices – Revenue and Forecast To 2028 (US$ Million)

Table 32. Australia: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 33. Australia: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 34. Australia: Embolotherapy Market, By Procedure – Revenue and Forecast To 2028 (US$ Million)

Table 35. Australia: Embolotherapy Market, By End User– Revenue and Forecast To 2028 (US$ Million)

Table 36. Rest of Asia Pacific: Embolotherapy Market, By Product – Revenue and Forecast To 2028 (US$ Million)

Table 37. Rest of Asia Pacific: Embolotherapy Market, By Embolic Agents – Revenue and Forecast To 2028 (US$ Million)

Table 38. Rest of Asia Pacific: Embolotherapy Market, By Support Devices – Revenue and Forecast To 2028 (US$ Million)

Table 39. Rest of Asia Pacific: Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 40. Rest of Asia Pacific: Embolotherapy Market, by Cancer– Revenue and Forecast to 2028 (US$ Million)

Table 41. Rest of Asia Pacific: Embolotherapy Market, By Procedure – Revenue and Forecast To 2028 (US$ Million)

Table 42. Rest Of Asia Pacific: Embolotherapy Market, By End User– Revenue and Forecast To 2028 (US$ Million)

Table 43. Organic Developments Done by Companies

Table 44. Inorganic Developments Done by Companies

Table 45. Glossary of Terms, Asia pacific Embolotherapy Market

LIST OF FIGURES

Figure 1. Asia Pacific Embolotherapy Market Segmentation

Figure 2. Asia Pacific Embolotherapy Market, By Country

Figure 3. Asia Pacific Embolotherapy Market Overview

Figure 4. Embolic Agents Held Largest Share of Product Segment in Asia Pacific Embolotherapy Market

Figure 5. Asia Pacific Embolotherapy Market in China to Show Remarkable Growth During Forecast Period

Figure 6. Asia Pacific Embolotherapy Market, Industry Landscape

Figure 7. Asia Pacific PEST Analysis

Figure 8. Asia Pacific Embolotherapy Market Impact Analysis of Drivers and Restraints

Figure 9. Asia Pacific Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10. Asia Pacific Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

Figure 11. Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12. Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13. Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14. Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15. Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16. Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19. Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21. Asia Pacific Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

Figure 22. Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Asia Pacific Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

Figure 32. Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Asia Pacific Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

Figure 36. Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Asia Pacific: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)

Figure 40. Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)

Figure 41. China: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Japan: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44. South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45. Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46. Rest of Asia Pacific: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)